A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Chan Soon-Shiong Institute for Medicine, El Segundo, California Atlantic Health, Summit, New Jersey Columbia University Irving Medical Center, New York, New York Taylor Cancer Center, Maumee, Ohio Age range
18 Years and older
Last updated February 2026